Fundamentals for The Cooper Companies, Inc.
COO's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect pr...
Business Operations:
Sector: HealthcareIndustry: Medical Instruments & Supplies
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Revenue projections:
Financial Ratios:
| currentRatio | 1.222000 |
|---|---|
| forwardPE | 13.253035 |
| debtToEquity | 33.634000 |
| earningsGrowth | 3.571000 |
| revenueGrowth | 0.006000 |
| grossMargins | 0.659280 |
| operatingMargins | 0.129340 |
| trailingEps | 2.880000 |
| forwardEps | 4.692510 |
The Cooper Companies, Inc.'s current ratio of 1.222 highlights the company's ability to easily cover its short-term debt using its available cash and assets. This indicates a strong liquidity position, ensuring The Cooper Companies, Inc. is unlikely to face difficulties in meeting immediate financial obligations.
COO's Forward PE ratio suggests the stock price is reasonable in relation to earnings. It's not overpriced, providing room for future growth, making the stock a potentially valuable investment for those seeking long-term gains.
COO's forward EPS is higher than its trailing EPS, suggesting the company is expected to improve its profitability this financial year. This reflects growing confidence in COO's earnings potential, with forecasts indicating better financial performance than in the prior year.
Price projections:
Insider Transactions:
9 separate purchases of COO stock were made, while market price was at 69.81333287556966 per share.No buy transactions were carried out during the period under review.COO has seen more sells than buys at current price levels, which could point to a potential price drop. If this selling trend persists, it may indicate that investors are expecting further declines in the stock's value.
Recommendation changes over time:
Analysts have shown a buy bias for The Cooper Companies, Inc., signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to The Cooper Companies, Inc., seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.